Lease Agreements in the Biotechnology Industry

2,369 Contracts & Agreements

Browse by Company

89bio, Inc. (3 contracts)
ACADIA PHARMACEUTICALS INC (10)
ACCELERON PHARMA INC (2)
Achaogen, Inc. (7)
ACHIEVE LIFE SCIENCES, INC. (8)
Acorda Therapeutics (4)
Actinium Pharmaceuticals, Inc. (2)
Acumen Pharmaceuticals, Inc. (2)
Adamas Pharmaceuticals Inc (9)
Adaptimmune Therapeutics PLC (5)
Adhera Therapeutics, Inc. (11)
ADiTx Therapeutics, Inc. (1)
ADMA BIOLOGICS, INC. (3)
ADURO BIOTECH, INC. (4)
Advaxis, Inc. (2)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (2)
Aerovate Therapeutics, Inc. (2)
AGENUS INC (23)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (12)
AILERON THERAPEUTICS INC (4)
Aimmune Therapeutics, Inc. (7)
AKCEA THERAPEUTICS, INC. (6)
Akebia Therapeutics, Inc. (9)
Akero Therapeutics, Inc. (1)
Akouos, Inc. (2)
ALBIREO PHARMA, INC. (9)
Aldeyra Therapeutics, Inc. (6)
Alector, Inc. (2)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (2)
Alkermes plc. (6)
Allakos Inc. (3)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (2)
Allogene Therapeutics, Inc. (7)
Allovir, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (14)
Alpha Healthcare Acquisition Corp. (5)
ALPINE IMMUNE SCIENCES, INC. (5)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (9)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (11)
ANAPTYSBIO INC (6)
ANAVEX LIFE SCIENCES CORP. (2)
Anika Therapeutics (11)
Annexon, Inc. (2)
Apellis Pharmaceuticals, Inc. (9)
APPLIED GENETIC TECHNOLOGIES CORP (6)
Applied Molecular Transport Inc. (4)
Aptevo Therapeutics Inc. (3)
Aptinyx Inc. (1)
AQUINOX PHARMACEUTICALS, INC (10)
Aravive, Inc. (4)
Arbutus Biopharma Corp (3)
ARCA biopharma, Inc. (14)
Arcellx, Inc. (1)
Arcturus Therapeutics Holdings Inc. (4)
Arcus Biosciences, Inc. (3)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (6)
ARENA PHARMACEUTICALS INC (5)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (9)
Arsanis, Inc. (7)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (7)
Athenex, Inc. (1)
ATOSSA GENETICS INC (8)
Atreca, Inc. (6)
aTYR PHARMA INC (5)
Aura Biosciences, Inc. (1)
Aurinia Pharmaceuticals Inc. (3)
AVEO PHARMACEUTICALS INC (11)
Avidity Biosciences, Inc. (4)
Avita Therapeutics, Inc. (3)
AVROBIO, Inc. (1)
Axcella Health Inc. (3)
Ayala Pharmaceuticals, Inc. (1)
BCTG Acquisition Corp. (1)
Beam Therapeutics Inc. (2)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (11)
BICYCLE THERAPEUTICS Ltd (1)
Big Cypress Acquisition Corp. (2)
BIO-PATH HOLDINGS INC (2)
bioAffinity Technologies, Inc. (2)
BioAtla, Inc. (1)
BioCardia, Inc. (7)
BIOCEPT INC (8)
BIOCRYST PHARMACEUTICALS INC (2)
Biogen Inc. (11)
BIOMARIN PHARMACEUTICAL INC (3)
Biomea Fusion, Inc. (2)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (9)
Biostage, Inc. (1)
BIOTIME INC (7)
BioXcel Therapeutics, Inc. (2)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (1)
bluebird bio, Inc. (11)
Blueprint Medicines Corp (6)
Bolt Biotherapeutics, Inc. (4)
BridgeBio Pharma, Inc. (1)
C4 Therapeutics, Inc. (2)
Cabaletta Bio, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (5)
Calithera Biosciences, Inc. (4)
Calyxt, Inc. (1)
CANCER GENETICS, INC (5)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (12)
Capstone Therapeutics Corp. (1)
CareDx, Inc. (5)
Caribou Biosciences, Inc. (3)
CASI Pharmaceuticals, Inc. (3)
CASTLE BIOSCIENCES INC (16)
Castle Creek Biosciences, Inc. (3)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (5)
CATALYST PHARMACEUTICALS, INC. (7)
Celcuity Inc. (6)
Celldex Therapeutics, Inc. (13)
Cellectar Biosciences, Inc. (3)
Cellular Biomedicine Group, Inc. (6)
Celsion CORP (3)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition Corp. (2)
Chelsea Worldwide Inc. (2)
ChemoCentryx, Inc. (6)
CHIMERIX INC (11)
Cidara Therapeutics, Inc. (8)
CM Life Sciences III Inc. (2)
Codiak BioSciences, Inc. (3)
Coherus BioSciences, Inc. (2)
Conatus Pharmaceuticals Inc. (7)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (1)
Constellation Alpha Capital Corp. (8)
CONSTELLATION PHARMACEUTICALS INC (4)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (7)
Cortexyme, Inc. (2)
Corvus Pharmaceuticals, Inc. (5)
Crinetics Pharmaceuticals, Inc. (1)
CRISPR Therapeutics AG (7)
CTI BIOPHARMA CORP (4)
Cullinan Oncology, LLC (1)
CURIS INC (4)
Cyclacel Pharmaceuticals, Inc. (6)
Cyclerion Therapeutics, Inc. (3)
Cytokinetics, Incorporated (8)
CytomX Therapeutics, Inc. (2)
CYTORI THERAPEUTICS, INC. (7)
CYTRX CORP (7)
Day One Biopharmaceuticals Holding Co LLC (2)
Decibel Therapeutics, Inc. (2)
Deciphera Pharmaceuticals, Inc. (4)
Denali Therapeutics Inc. (2)
Dermavant Sciences Ltd (3)
Dermira, Inc. (4)
Design Therapeutics, Inc. (2)
DiaMedica Therapeutics Inc. (6)
Dicerna Pharmaceuticals Inc (5)
Diffusion Pharmaceuticals Inc. (2)
DYADIC INTERNATIONAL INC (4)
Dynamics Special Purpose Corp. (5)
DYNAVAX TECHNOLOGIES CORP (8)
Dyne Therapeutics, Inc. (5)
Eagle Pharmaceuticals, Inc. (2)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (1)
Eidos Therapeutics, Inc. (3)
Eiger BioPharmaceuticals, Inc. (5)
Emerald Bioscience, Inc. (4)
Emergent BioSolutions Inc. (7)
Enanta Pharmaceuticals, Inc. (6)
Enochian Biosciences Inc (4)
Entrada Therapeutics, Inc. (1)
Environmental Impact Acquisition Corp (4)
ENZON PHARMACEUTICALS, INC. (2)
Epizyme, Inc. (7)
Equillium, Inc. (1)
Erasca, Inc. (2)
Esperion Therapeutics, Inc. (7)
Evelo Biosciences, Inc. (3)
EXACT SCIENCES CORP (13)
Exelixis (35)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (9)
FENNEC PHARMACEUTICALS INC. (2)
Fibrocell Science, Inc. (3)
FIBROGEN INC (1)
Finch Therapeutics Group, Inc. (4)
FIVE PRIME THERAPEUTICS INC (5)
Flex Pharma, Inc. (2)
Flexion Therapeutics Inc (10)
FLUOROPHARMA MEDICAL, INC. (2)
Foghorn Therapeutics Inc. (3)
Forma Therapeutics Holdings, Inc., (4)
Forty Seven, Inc. (3)
Frequency Therapeutics, Inc. (5)
FS Development Corp. (1)
Fusion Pharmaceuticals Inc. (4)
G1 Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (1)
Galecto Inc. (2)
Gemphire Therapeutics Inc. (5)
Gene Biotherapeutics, Inc. (3)
GENELUX CORP (4)
Generation Bio Co. (3)
GENOCEA BIOSCIENCES, INC. (5)
GeoVax Labs, Inc. (5)
GERON CORP (9)
Global Blood Therapeutics, Inc. (5)
GLYCOMIMETICS INC (4)
GOLDENWELL BIOTECH, INC. (1)
Gossamer Bio, Inc. (3)
Grail, Inc. (3)
Graphite Bio, Inc. (2)
Gritstone Oncology, Inc. (6)
GT Biopharma, Inc. (2)
GTX INC (8)
GX Acquisition Corp. (1)
HALOZYME THERAPEUTICS INC (8)
HARBOR DIVERSIFIED, INC. (1)
Harpoon Therapeutics, Inc. (3)
HEAT BIOLOGICS, INC. (8)
HedgePath Pharmaceuticals, Inc. (1)
HEMISPHERX BIOPHARMA INC (3)
HERON THERAPEUTICS, INC. (9)
HISTOGENICS CORP (8)
Homology Medicines, Inc. (3)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (2)
iBio, Inc. (2)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (4)
IDERA PHARMACEUTICALS, INC. (4)
IGM Biosciences, Inc. (2)
IMMUNE PHARMACEUTICALS INC (1)
Immuneering Corp (1)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (13)
IMMUNOMEDICS INC (1)
IMPEL NEUROPHARMA INC (1)
Incyte (5)
INFINITY PHARMACEUTICALS, INC. (14)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (2)
InMed Pharmaceuticals Inc. (1)
Inmune Bio, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (4)
Inozyme Pharma, Inc. (2)
INSMED Inc (12)
Intellia Therapeutics, Inc. (6)
INTERCEPT PHARMACEUTICALS, INC. (11)
International Stem Cell CORP (6)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (1)
IOVANCE BIOTHERAPEUTICS, INC. (11)
IRONWOOD PHARMACEUTICALS INC (16)
Isoray, Inc. (4)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (4)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (5)
Karuna Therapeutics, Inc. (2)
Karyopharm Therapeutics Inc. (6)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (2)
Kindred Biosciences, Inc. (4)
Kiniksa Pharmaceuticals, Ltd. (5)
Kinnate Biopharma Inc. (2)
Kiromic Biopharma, Inc. (6)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
Kodiak Sciences Inc. (1)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (17)
Kura Oncology, Inc. (14)
Kymera Therapeutics, Inc. (1)
LEAP THERAPEUTICS, INC. (8)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (5)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (7)
Locust Walk Acquisition Corp. (2)
LogicBio Therapeutics, Inc. (1)
LONGEVERON LLC (1)
Lyell Immunopharma, Inc. (5)
MACROGENICS INC (12)
MADRIGAL PHARMACEUTICALS, INC. (6)
Magenta Therapeutics, Inc. (4)
MANNKIND CORP (3)
MARIZYME INC (2)
MATEON THERAPEUTICS INC (8)
Matinas BioPharma Holdings, Inc. (2)
MAXCYTE, INC. (9)
MEDICINOVA INC (2)
MeiraGTx Holdings plc (9)
MERRIMACK PHARMACEUTICALS INC (12)
Mersana Therapeutics, Inc. (4)
Merus N.V. (3)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (7)
MiMedx Group, Inc. (9)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (12)
Mirati Therapeutics, Inc. (9)
Mirum Pharmaceuticals, Inc. (2)
Moderna, Inc. (2)
Molecular Templates, Inc. (12)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (16)
Monte Rosa Therapeutics, Inc. (3)
Morphic Holding, Inc. (2)
MUSTANG BIO, INC. (5)
Myriad Genetics, Inc. (8)
NantKwest, Inc. (20)
Natera, Inc. (5)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (4)
NEUROCRINE BIOSCIENCES INC (5)
Neurotrope, Inc. (1)
NexImmune, Inc. (2)
NextCure, Inc. (4)
Nkarta, Inc. (11)
NORTHWEST BIOTHERAPEUTICS INC (4)
NOVAVAX INC (27)
Novus Therapeutics, Inc. (6)
NTN BUZZTIME INC (14)
Nurix Therapeutics, Inc. (3)
Ohr Pharmaceutical Inc (9)
Olivia Ventures, Inc. (1)
Omega Therapeutics, Inc. (3)
OncoCyte Corp (2)
Oncorus, Inc. (6)
ONCOSEC MEDICAL Inc (8)
OPGEN INC (10)
Ophthotech Corp. (7)
Opko Health, Inc. (2)
ORAGENICS INC (3)
Orchard Therapeutics plc (1)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (10)
ORGANOVO HOLDINGS, INC. (7)
Oric Pharmaceuticals, Inc. (2)
Outlook Therapeutics, Inc. (8)
Passage BIO, Inc. (4)
PDL BIOPHARMA, INC. (10)
Pfenex Inc. (4)
PhaseBio Pharmaceuticals Inc (1)
Phio Pharmaceuticals Corp. (4)
PIERIS PHARMACEUTICALS, INC. (4)
PLURISTEM THERAPEUTICS INC (1)
PMV Pharmaceuticals, Inc. (2)
POLARITYTE, INC. (7)
PORTOLA PHARMACEUTICALS INC (3)
Poseida Therapeutics, Inc. (4)
Praxis Precision Medicines, Inc. (3)
PRECISION BIOSCIENCES INC (9)
Prelude Therapeutics Inc (3)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (3)
Progenics Pharmaceuticals, Inc. (3)
Prometheus Biosciences, Inc. (2)
Protagenic Therapeutics, Inc. (2)
Protagonist Therapeutics, Inc (8)
Protalix BioTherapeutics, Inc. (2)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (10)
Prothena Corp plc (3)
PTC THERAPEUTICS, INC. (5)
PUMA BIOTECHNOLOGY, INC. (5)
Pyxis Oncology, Inc. (1)
Radius Health, Inc. (11)
RAPT Therapeutics, Inc. (4)
RECURSION PHARMACEUTICALS, INC. (10)
Regeneron Pharmaceuticals (18)
REGENXBIO Inc. (14)
Regulus Therapeutics Inc. (12)
Relay Therapeutics, Inc. (1)
Repare Therapeutics Inc. (11)
Replimune Group, Inc. (3)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (9)
REXAHN PHARMACEUTICALS, INC. (12)
Rezolute, Inc. (2)
RHYTHM PHARMACEUTICALS, INC. (3)
RIGEL PHARMACEUTICALS INC (8)
RITTER PHARMACEUTICALS INC (2)
ROCKET PHARMACEUTICALS, INC. (9)
Rubius Therapeutics, Inc. (2)
Sage Therapeutics, Inc. (10)
Sana Biotechnology, Inc. (2)
SANGAMO THERAPEUTICS, INC (11)
Sarepta Therapeutics, Inc. (12)
Savara Inc (6)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (8)
SELECTA BIOSCIENCES INC (3)
SELLAS Life Sciences Group, Inc. (7)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (4)
Seres Therapeutics, Inc. (4)
Sesen Bio, Inc. (3)
Shattuck Labs, Inc. (2)
Sierra Oncology, Inc. (6)
Sigilon Therapeutics, Inc. (5)
Silverback Therapeutics, Inc. (4)
SOLENO THERAPEUTICS INC (3)
Solid Biosciences Inc. (4)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (6)
Spectrum Pharmaceuticals, Inc. (8)
Spero Therapeutics, Inc. (3)
SPHERIX INC (1)
Spinning Eagle Acquisition Corp. (3)
Spring Bank Pharmaceuticals, Inc. (5)
SpringWorks Therapeutics, Inc. (1)
SPRUCE BIOSCIENCES, INC. (2)
SQZ Biotechnologies Co (1)
Stellar Biotechnologies, Inc. (7)
Stoke Therapeutics, Inc. (4)
Summit Therapeutics Inc. (1)
SUNESIS PHARMACEUTICALS INC (9)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (2)
SYNLOGIC, INC. (4)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (10)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (2)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (2)
Tenaya Therapeutics, Inc. (2)
Tocagen Inc (6)
Tonix Pharmaceuticals Holding Corp. (3)
Tracon Pharmaceuticals, Inc. (2)
Translate Bio, Inc. (1)
TREVENA INC (8)
Trovagene, Inc. (5)
TScan Therapeutics, Inc. (2)
Turning Point Therapeutics, Inc. (7)
Twist Bioscience Corp (12)
Tyra Biosciences, Inc. (3)
U.S. Stem Cell, Inc. (5)
Ultragenyx Pharmaceutical Inc. (18)
uniQure N.V. (3)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (4)
UroGen Pharma Ltd. (2)
Vanda Pharmaceuticals Inc. (11)
Vaxart, Inc. (5)
Vaxcyte, Inc. (4)
VBI Vaccines Inc (16)
VERACYTE, INC. (5)
Verastem, Inc. (3)
Vericel Corp (4)
Vertex Pharmaceuticals Inc (7)
Verve Therapeutics, Inc. (4)
VICAL INC (4)
Viela Bio, Inc. (1)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (4)
Vir Biotechnology, Inc. (2)
VistaGen Therapeutics, Inc. (3)
VITAL THERAPIES INC (4)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (3)
Voyager Therapeutics, Inc. (10)
Werewolf Therapeutics, Inc. (3)
WINDTREE THERAPEUTICS INC (8)
XBiotech Inc. (4)
Xencor Inc (9)
Xenetic Biosciences, Inc. (2)
Xenon Pharmaceuticals Inc. (5)
Xilio Therapeutics, Inc. (1)
XOMA Corp (7)
YIELD10 BIOSCIENCE, INC. (7)
ZAFGEN, INC. (6)
Zai Lab Ltd (1)
Zentalis Pharmaceuticals, LLC (10)
ZIOPHARM ONCOLOGY INC (5)
Zymeworks Inc. (2)

Recent Contracts

Agreement for Modification of Lease and Voluntary Surrender of Premises, dated as of September 20, 2023, by and between ARE-San Francisco No. 63, LLC and Atreca, Inc (Atreca, Inc., Filed With SEC on September 21, 2023)
Assignment and Assumption of Lease Agreement, effective September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
Office Lease, dated July 31, 2019, by and between Village Oaks Pathology Services, P.A. and 343 West Sunset, LLC (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
First Amendment to Lease Agreement, by and between Voyager Therapeutics, Inc. and LS 75 Hayden, LLC, dated August 11, 2023 (Voyager Therapeutics, Inc., Filed With SEC on August 16, 2023)
Lease Termination Agreement, dated August 7, 2023, between the Company and San Diego Sycamore, LLC (Conatus Pharmaceuticals Inc., Filed With SEC on August 10, 2023)
Fourth Amendment to Lease, dated June 14, 2023, by and between HCP BTC, LLC and Nkarta, Inc (Nkarta, Inc., Filed With SEC on August 10, 2023)
Third Amendment to Lease, effective as of July 25, 2023, by and between Eastland Regency, L.C. and the Registrant (SERA PROGNOSTICS, INC., Filed With SEC on August 9, 2023)
Extension of Commercial Lease by and between 605 Doug St, LLC and ImmunityBio, Inc., dated June 30, 2023 (NantKwest, Inc., Filed With SEC on August 8, 2023)
Amendment to lease agreement, dated April 24, 2023, by and between Soleno Therapeutics, Inc. and Hudson Towers at Shore Center, LLC (SOLENO THERAPEUTICS INC, Filed With SEC on August 8, 2023)
Amended and Restated Office Lease, dated June 27, 2023, by and between ROIC California, LLC and Skye Bioscience, Inc (Emerald Bioscience, Inc., Filed With SEC on August 7, 2023)
Amendment to Lease Agreement by and between the Registrant and Are-Winter Street Property, LLC, dated as of June 20, 2023 (Intellia Therapeutics, Inc., Filed With SEC on August 3, 2023)
First Amendment to Lease between Omega Therapeutics, Inc. and ARE-MA Region No. 94, LLC, dated May 3, 2023 (Omega Therapeutics, Inc., Filed With SEC on August 3, 2023)
Lease Termination Agreement, dated as of June 15, 2023, by and between BMR-Hampshire LLC and Surface Oncology, Inc (Surface Oncology, Inc., Filed With SEC on August 2, 2023)
Sixth Amendment of Sublease, dated May 24, 2023, by and between Kiniksa Pharmaceuticals Corp. and 92 Hayden Avenue Trust (Kiniksa Pharmaceuticals, Ltd., Filed With SEC on August 1, 2023)
Sublease Termination and Surrender Agreement, executed as of July 14, 2023, by and between Evelo Biosciences, Inc. and Bio-Rad Laboratories, Inc (Evelo Biosciences, Inc., Filed With SEC on July 20, 2023)
Second Amendment to Sublease, dated April 27, 2023, between the Company and The Paul Revere Life Insurance Company (MUSTANG BIO, INC., Filed With SEC on July 20, 2023)
Third Amendment to Sublease, dated June 15, 2023, between the Company and The Paul Revere Life Insurance Company (MUSTANG BIO, INC., Filed With SEC on July 20, 2023)
Assignment of Lease by and between TCR2 Therapeutics Inc. and AstraZeneca Pharmaceuticals LP, dated May 23, 2023 (TCR2 THERAPEUTICS INC., Filed With SEC on May 24, 2023)
Lease Modification Agreement by and between TCR2 Therapeutics Inc. and ARE-Maryland No. 31, LLC, dated May 23, 2023 (TCR2 THERAPEUTICS INC., Filed With SEC on May 24, 2023)
Lease Agreement, dated as of (Replimune Group, Inc., Filed With SEC on May 18, 2023)
Lease Termination Agreement, dated as of May 12, 2023, by and between the Company and NRL WCS 200 Inner Belt Prop, LLC (Finch Therapeutics Group, Inc., Filed With SEC on May 18, 2023)
Sixteenth Amendment to Lease Agreement, by and between the Registrant and 3030 Bunker Hill Owner (DE) LLC, dated January 26, 2023 (GENELUX CORP, Filed With SEC on May 15, 2023)
Lease Agreement between the Registrant and the University of Louisville, dated as of November 1, 2018, as amended on (Talaris Therapeutics, Inc., Filed With SEC on May 15, 2023)
Sublease Termination and Release Agreement by and between the Registrant and Novartis Institutes for Biomedical Research, Inc., dated as of March 31, 2023 (Magenta Therapeutics, Inc., Filed With SEC on May 15, 2023)
Lease Document between Viewpoint Molecular Targeting, Inc. and the University of Iowa Bioventures Center, dated February 21, 2023 (Isoray, Inc., Filed With SEC on May 15, 2023)
Third Amendment to Lease and First Amendment to Consent to Sublease between Adverum NC, LLC (a wholly owned subsidiary of the Company), ARE-NC REGION NO. 21, LLC and Jaguar Gene... (Adverum Biotechnologies, Inc., Filed With SEC on May 11, 2023)
Lease, dated April 22, 2019, by and between Wexford-SCEC 3675 Market Street, LLC and CARISMA Therapeutics Inc (Sesen Bio, Inc., Filed With SEC on May 11, 2023)
Seventh Amendment to Lease by and between the Registrant and Nancy Ridge Technology Center, L.P., dated April 20, 2023 (Cidara Therapeutics, Inc., Filed With SEC on May 11, 2023)
Lease agreement between URP X LLC and AVITA Medical, Inc. dated May 11, 2023 (Avita Therapeutics, Inc., Filed With SEC on May 11, 2023)
Third Amendment to Lease, dated May 2, 2023, by and between Applied Molecular Transport Inc. and ARE-East Jamie Court, LLC (Applied Molecular Transport Inc., Filed With SEC on May 11, 2023)
Third Amendment to Lease, dated April 25, 2023, by and between HCP BTC, LLC and Nkarta, Inc (Nkarta, Inc., Filed With SEC on May 11, 2023)
Agreement for Modification of Lease and Voluntary Surrender of Premises, dated May 2, 2023, by and between Applied Molecular Transport Inc. and ARE-East Jamie Court, LLC (Applied Molecular Transport Inc., Filed With SEC on May 11, 2023)
Sublease, effective March 6, 2023, between Zentalis Pharmaceuticals, Inc. and L.M. Cohen & Co. LLP Certified Public Accountants, as amended on April 10, 2023 (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 10, 2023)
Sixth Amendment to Lease Agreement, dated April 19, 2023, by and between the Company and ARE-8000/9000-10000 Virginia Manor, LLC (NextCure, Inc., Filed With SEC on May 4, 2023)
First Amendment to Lease, by and between the Registrant and Revolution Labs Owner, LLC, dated January 6, 2023 (Keros Therapeutics, Inc., Filed With SEC on May 4, 2023)
Lease Termination Agreement, by and between the Company and the Landlord, dated May 2, 2023 (Jounce Therapeutics, Inc., Filed With SEC on May 4, 2023)
Fourth Amendment to Standard Office Lease, dated April 18, 2023, by and between the Registrant and Alturas Siete II, LLC (CASTLE BIOSCIENCES INC, Filed With SEC on May 3, 2023)
Third Amendment to Lease Agreement, dated April 19, 2023, by and between GlycoMimetics, Inc. and ARE-Maryland No. 45, LLC (GLYCOMIMETICS INC, Filed With SEC on April 21, 2023)
Third Amendment to Lease Agreement dated November 24, 2014 between TR Stone Manor Corp. and Windtree (WINDTREE THERAPEUTICS INC, Filed With SEC on March 31, 2023)
Fifth Amendment to Lease Agreement, dated as of December 29, 2022, by and between Fresh Tracks Therapeutics, Inc. and BRE-BMR Flatiron VII LLC (f/k/a GPIF 5777 Flatiron LLC and... (VICAL INC, Filed With SEC on March 30, 2023)